Download PDF
Endoscopy 2002; 34(9): 690-697
DOI: 10.1055/s-2002-33565
Original Article

© Georg Thieme Verlag Stuttgart · New York

Endoscopic Variceal Ligation plus Propranolol vs. Transjugular Intrahepatic Portosystemic Stent Shunt: A Long-Term Randomized Trial

P.  Sauer 1 , J.  Hansmann 2 , G.  M.  Richter 2 , W.  Stremmel 1 , A.  Stiehl 1
  • 1Department of Internal Medicine, University of Heidelberg, Germany
  • 2Department of Radiology, University of Heidelberg, Germany
Further Information

Publication History

Submitted: 20 December 2001

Accepted after Revision: 26 April 2002

Publication Date:
26 August 2002 (online)

Also available at
    Permissions and Reprints

Background and Study Aims: After a first variceal bleeding episode in patients with cirrhosis of the liver, treatment with transjugular intrahepatic portosystemic stent shunt (TIPS) and endoscopic variceal ligation (EVL) plus propranolol were compared, with regard to prevention of variceal rebleeding, complications, and mortality.
Patients and Methods: 85 patients were randomly allocated to receive TIPS (n = 43) or EVL (n = 42). The groups were comparable regarding age, sex, etiology of liver cirrhosis, and liver function.
Results: The mean observation times were 4.1 years in the TIPS group and 3.6 years in the EVL group. Although the probability of rebleeding was higher in the EVL group (29.9 %) than in the TIPS group (19.4 %), the difference was not statistically significant. Three of five patients of the EVL group successfully underwent TIPS placement after treatment failure. The probability of TIPS dysfunction requiring shunt revision was 89 %. Hepatic encephalopathy was observed more often in the TIPS group (40.5 %) than in the EVL group (20.5 %; P < 0.05). The probability of survival was similar in both groups (TIPS group 75.9 %, EVL group 82.2 %; n.s.).
Conclusions: In view of its good efficacy and the lower cost of treatment, endoscopic ligation plus propranolol may be recommended as initial procedure for prevention of recurrent variceal hemorrhage, whereas TIPS seems to be the preferable procedure in patients with recurrent bleeding after adequate endoscopic and pharmacological treatment.

References

  • 1 Bosch J. Medical treatment of portal hypertension.  Digestion. 1998;  59 547-555
    CrossrefPubMedSearch in Google Scholar
  • 2 D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review.  Hepatology. 1995;  22 332-354
    CrossrefPubMedSearch in Google Scholar
  • 3 Bosch J, Garcia-Pagan J C, Feu F, Rodes J. Portal hypertension: Clinical pathobiology. In: Arias IM, Boyer JL, Fausto N, et al. (eds) The liver: Biology and pathobiology. New York; Raven Press 1994: 1343-1355
    Search in Google Scholar
  • 4 Stiegmann G V, Goff J S, Michaletz-Onody P A. et al . Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.  N Engl J Med. 1992;  326 1521-1527
    PubMedSearch in Google Scholar
  • 5 Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis.  Ann Intern Med. 1995;  123 280-287
    PubMedSearch in Google Scholar
  • 6 Sarin S K, Govil A, Jain A K. et al . Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence.  J Hepatol. 1997;  26 826-832
    CrossrefPubMedSearch in Google Scholar
  • 7 Avgerinos A, Armonis A, Manolakopoulos S. et al . Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study.  J Hepatol. 1997;  26 1034-1041
    CrossrefPubMedSearch in Google Scholar
  • 8 Baroncini D, Milandri G L, Borioni D. et al . A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices.  Endoscopy. 1997;  29 235-240
    PubMedSearch in Google Scholar
  • 9 Sanyal A J, Freedman A M, Purdum P P. et al . Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage: A randomized prospective trial.  Ann Intern Med. 1997;  126 849-857
    PubMedSearch in Google Scholar
  • 10 Cabrera J, Maynar M, Granados R. et al . Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.  Gastroenterology. 1996;  110 832-839
    PubMedSearch in Google Scholar
  • 11 Cello J P, Ring E J, Olcott E W. et al . Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage.  Ann Intern Med. 1997;  126 858-865
    PubMedSearch in Google Scholar
  • 12 Garcia-Villareal L, Martinez-Lagares F, Siebra A. et al . Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage.  Hepatology. 1999;  29 27-32
    CrossrefPubMedSearch in Google Scholar
  • 13 Rössle M, Deibert P, Haag K. et al . Randomised trial of transjugular intrahepatic portosystemic stent shunt versus endoscopy plus propranolol for variceal rebleeding.  Lancet. 1997;  349 1043-1049
    CrossrefPubMedSearch in Google Scholar
  • 14 Sauer P, Theilmann L, Stremmel W. et al . Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding.  Gastroenterology. 1997;  113 1623-1631
    PubMedSearch in Google Scholar
  • 15 Merli M, Salerno F, Riggio O. et al . Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: A randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T).  Hepatology. 1998;  27 48-53
    CrossrefPubMedSearch in Google Scholar
  • 16 Jalan R, Forrest E H, Stanley A J. et al . A randomized trial comparing transjugular intrahepatic porto systemic stent shunt with variceal band ligation in the prevention of rebleeding from esophageal varices.  Hepatology. 1997;  26 1115-1122
    PubMedSearch in Google Scholar
  • 17 Pomier-Layrargues G, Villeneuve J P, Deschenes M. et al . Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: A randomised trial.  Gut. 2001;  48 390-396
    CrossrefPubMedSearch in Google Scholar
  • 18 Papatheodoridis G V, Goulis J, Leandro G. et al . Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.  Hepatology. 1999;  30 612-622
    CrossrefPubMedSearch in Google Scholar
  • 19 Luca A, D'Amico G, LaGalla R. et al . TIPS for prevention of recurrent bleeding in patients with cirrhosis: A meta-analysis of randomized trials.  Radiology. 1999;  212 411-421
    CrossrefPubMedSearch in Google Scholar
  • 20 Tait I S, Krige J EJ, Terblanche J. Endoscopic band ligation of esophageal varices.  Br J Surg. 1999;  86 437-446
    CrossrefPubMedSearch in Google Scholar
  • 21 Richter G M, Noeldge G, Palmaz J C. et al . Transjugular intrahepatic portocaval stent shunt. Preliminary clinical results.  Radiology. 1990;  174 1027-1030
    CrossrefPubMedSearch in Google Scholar
  • 22 DeFranchis R, Pascal J P, Ancona E. et al . Definitions, methodology and therapeutic strategies in portal hypertension.  J Hepatol. 1992;  15 256-261
    CrossrefPubMedSearch in Google Scholar
  • 23 Conn H O. Trailmarking and number connection tests in the assessment of mental state in portal systemic encephalopathy.  Dig Dis. 1977;  22 541-550
    CrossrefPubMedSearch in Google Scholar
  • 24 Merkel M, Morabito A. Adding beta-blockers to sclerotherapy in the prevention of variceal rebleeding. A meta-analysis assessment.  J Hepatol. 1994;  21 918-919
    CrossrefPubMedSearch in Google Scholar
  • 25 Bosch J, Garcia-Pagan J C. Complications of cirrhosis I. Portal hypertension.  J Hepatol. 2000;  32 141-156
    CrossrefPubMedSearch in Google Scholar
  • 26 Lo G H, Lai K H, Cheng J S. et al . Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: A prospective randomized trial.  Hepatology. 2000;  32 461-465
    CrossrefPubMedSearch in Google Scholar
  • 27 Merkel C, Bolognesi M, Sacerdoti D. et al . The heodynamic response to medical treatment of portal hypertension as a predictor of clinical effectivness in the primary prophylaxis of variceal bleeding in cirrhosis.  Hepatology. 2000;  32 930-934
    CrossrefPubMedSearch in Google Scholar
  • 28 Bohnacker S, Maydeo A, Soehendra N. Variceal bleeding and portal hypertension: Still a therapeutic challenge.  Endoscopy. 1999;  31 26-37
    Thieme ConnectPubMedSearch in Google Scholar
  • 29 Lo G H, Lai K H, Cheng J S. et al . The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective, randomized trial.  Hepatology. 1998;  28 391-395
    CrossrefPubMedSearch in Google Scholar
  • 30 Djurdjevic D, Janosevic S, Dapcevic B. et al . Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: A randomized and prospective study.  Endoscopy. 1999;  31 286-290
    Thieme ConnectPubMedSearch in Google Scholar
  • 31 Garg P K, Joshi Y K, Tandon R K. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: A prospective randomized study.  Gastrointest Endosc. 1999;  50 369-373
    CrossrefPubMedSearch in Google Scholar
  • 32 Saeed Z A, Stiegmann G V, Ramirez F C. et al . Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial.  Hepatology. 1997;  25 71-74
    CrossrefPubMedSearch in Google Scholar
  • 33 Graham D Y, Smith J L. The course of patients after variceal hemorrhage.  Gastroenterology. 1981;  80 800-809
    CrossrefPubMedSearch in Google Scholar
  • 34 Pagliaro L, D'Amico G, Pasta L. et al .Portal hypertension in cirrhosis: Natural history. In: Bosch J, Groszmann R, editors Portal hypertension: Pathophysiology and treatment. Cambridge, MA; Blackwell Scientific 1994: 72-92
    Search in Google Scholar
  • 35 Roessle M, Haag K, Ochs A. et al . The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding.  N Engl J Med. 1994;  330 165-171
    CrossrefPubMedSearch in Google Scholar
  • 36 Lind C D, Malisch T W, Chong W K. et al . Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement.  Gastroenterology. 1994;  106 1277-1283
    PubMedSearch in Google Scholar
  • 37 Haskal Z J, Pentecost M J, Soulen M C. et al . Transjugular intrahepatic portosystemic shunt stenosis and revision: Early and midterm results.  AJR Am J Roentgenol. 1994;  192 231-234
    PubMedSearch in Google Scholar
  • 38 Sauer P, Theilmann L, Herrmann S. et al . Phenprocoumon for prevention of shunt occlusion after transjugular intrahepatic portosystemic stent shunt: A randomized trial.  Hepatology. 1996;  24 1433-1436
    PubMedSearch in Google Scholar
  • 39 Richter G M, Noeldge G, Brado M. et al . TIPSS: 10 years of clinical experience.  Rofo Fortschr Geb Roentgenstr Neuen Bildgeb Verfahr. 1998;  168 307-315
    PubMedSearch in Google Scholar
  • 40 Hansmann H J, Noldge G, Leutloff U. et al . Radiologic after-care of transjugular intrahepatic stent shunt.  Radiologe. 2001;  41 884-890
    CrossrefPubMedSearch in Google Scholar

P. Sauer, M.D.

Medizinische Universitätsklinik · Innere Medizin IV

Bergheimer Strasse 58 · 69115 Heidelberg · Germany

Fax: + 49-6221-565687

Email: peter_sauer@med.uni-heidelberg.de